Posted on

Hollister Biosciences Inc. Division Rebel Hemp Company to Launch Hemp Brewed Beverage “Rebel Tea”

Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB (the “Company“, “Hollister Cannabis Co.” or “Hollister“) – through its hemp division, Rebel Hemp Company is proud to announce the launch of its premium organic hemp-brewed beverage, Rebel Tea, at the Dream House MJBiz VIP Event in Las Vegas, Nevada.

Brewed with high-quality, American-grown hemp and containing fifteen milligrams of whole-plant full-spectrum phytocannabinoids, Rebel Tea offers consumers a refreshing THC-free beverage. Rebel Tea’s innovative formula features exclusively organic ingredients paired with light flavoring from natural lemon and cane sugar.

Rebel Tea will be launched at the most-anticipated after-party of the MJBiz Conference, the Dream House MJBiz VIP Event on December 12, 2019, at The Industrial Event Space at 2330 S. Industrial Road in Las Vegas, Nevada. Hollister, a sponsor of the invite-only event, will be showcasing Rebel Tea, along with additional hemp and THC products, while offering VIP’s an exclusive on-site adult consumption area in “The Den”.

The CEO of Hollister Biosciences Inc., Carl Saling shared, “We are very proud to release our new hemp beverage Rebel Tea. We have worked long and hard to create this amazing tea that is actually brewed from hemp.”.

About Hollister Biosciences Inc.: Hollister Biosciences Inc. is a California based vertically integrated cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality California-grown cannabis & hemp products. Hollister uses a vertically integrated, high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Cannabis Co include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker.”

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate“, “continue“, “estimate”, “expect”, “may”, “will”, “would”, “project“, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

Posted on

Wuhan Closes Acquisition of Biodelta Nutraceuticals Assets

Wuhan General Group (China), Inc. (OTC PINK: WUHN) (the “Company” and “Wuhan”), is pleased to announce the closing of our previously announced Letter of Intent to acquire 49% of Biodelta Nutraceuticals, Ltd. assets which includes the land, the buildings, and the infrastructure as well as the specialized greenhouse and drying ovens. These assets will be part of our new operational facility located near Cape Town, South Africa (“Acquisition”). Total consideration for the Acquisition is US$1.567 million paid in cash.

This transaction enables Wuhan to produce 36,000 kg of marijuana in phase one (300k sq. ft), and 175,000 kg (1.3M sq. ft) in phase 2. In addition, the facility will permit Wuhan to produce a very high-end organic CBD, eliminating market shortage risk and guaranteeing supply.

About Biodelta Nutraceuticals

Biodelta Nutraceuticals (ISO 22000 and organic certified) is a Cape Town-based manufacturer and merchandiser of premium health products to all pharmacy & health shop chains across South Africa. For the past 12 years, Biodelta has developed, designed and produced more than 1,000 products for these customers and is now strategically positioned to launch CBD products through these channels. In addition, Biodelta has license applications in process for growing, extracting and product development as well as dossiers for various CBD based products.

For further information contact:

Website: https://biodelta.net

Public Relations E-mail: info@biodelta.net

About Wuhan General Group (China), Inc.

Wuhan General Group (China), Inc. through its wholly-owned subsidiary MJ MedTech is a nutraceutical biotechnology company that researches, develops and commercializes a range of CBD-based products under the Dr. AnnaRx brand. In addition, its new division, M2BIO aims to explore and develop additional indications for psilocybin new therapies that will help patients who suffer from mental illness. Our mission is to advance botanical-based medicine to the forefront by deploying best practice science and medicine, clinical research and emerging technologies.

For further information contact:

Publicly traded company (OTC Pink: WUHN)

Website: www.wuhn.org

Public Relations E-mail: info@wuhn.org

Forward-Looking Statements:

Safe Harbour Statement – In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company’s future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company’s business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company’s website. The Company disclaims any responsibility to update any forward-looking statements.

 

 

Contacts

Wuhan General Group (China), Inc.
Ramy Kamaneh
514 781 7368
info@wuhn.org

Posted on

Helping 92% of cancer patients

Cancer patients in drug therapy experience

If cancer patients have the right to end their suffering through assisted suicide, shouldn’t they have the right to end their suffering through psilocybin therapy?

In a Johns Hopkins study, 92% of cancer patients saw significant reductions in depression and anxiety 5 weeks after a single high dose of psilocybin. After 6 months, 78% still had significant reductions in symptoms.

Many of the 51 participants described a sense of infinite love, peace, and oneness, and several were able to come to conquer their fear of death.

“It was so powerful and so profound that it just took my breath away… I feel like it changed my life”, said one participant, Anthony Head.